PRESENTATIONS

In 2022, the Global Health Registry formally merged with the Cost-Effectiveness Analysis (CEA) Registry. This site only contains data through 2020 publications. For the most up-to-date data, please visit the new database: https://cear.tuftsmedicalcenter.org/

As part of CEVR’s Global Health Initiative, all available data from cost-per-DALY publications remain free of charge: https://cear.tuftsmedicalcenter.org/registry/download

The Model Clearinghouse on this site is still active and monitored.

Webinar:

March 2021:

          Webinar recording: 

          Is My Global Health Intervention Worth the Investment? An Overview of Tools and Techniques – Webinar, March 26th 2021 (recording)

          Powerpoint slides:

          Is My Global Health Intervention Worth the Investment? An Overview of Tools and Techniques – Webinar, March 26th 2021 (powerpoint)

July 2020:

          Webinar recording: 

          Getting our priorities straight: Aligning cost-Effectiveness evidence with disease burden – webinar, July 24th 2020 (recording)

          Powerpoint slides:

          Getting our priorities straight: Aligning cost-Effectiveness evidence with disease burden – webinar, July 24th 2020 (powerpoint)

September 2019:

          Webinar recording: 

          The state of global health cost-effectiveness analysis: Insights for action – Webinar, September 10th 2019 (recording)

          Powerpoint slides:

          The state of global health cost-effectiveness analysis: Insights for action – Webinar, September 10th 2019 (powerpoint)

July 2018:

           Webinar recording:

           Prioritizing global health resources: using cost-effectiveness analysis – Webinar, July 19th 2018(recording)

           Powerpoint slides:

            Prioritizing global health resources: using cost-effectiveness analysis – Webinar, July 19th 2018 (powerpoint)

Conferences: 

D’Cruz B., Ollendorf D., Bacon R. Use of Cost-Effectiveness Analysis as a Policymaking Tool to Identify “Best Buy” Interventions for Non-Communicable Diseases. Unite for Sight International Meeting; New Haven CT. April 2019. Oral presentation

Emerson JE, Panzer AD, Cohen JT, Neumann PJ, Kim DD. How Well do Economic Evaluations in Global Health Settings Adhere to the iDSI Reference Case? Society for Medical Decision Making (SMDM) 40th International Meeting. October 2018. Poster Presentation

Neumann PJ, D'Cruz BN, Emerson JE, Panzer AD, Anderson JE, Pope EF, Kim DD, Cohen JT. The Growth of Cost-Effectiveness Analyses in Asia. ISPOR ASIA International Meeting; Tokyo Japan. September 2018. Poster Presentation

Neumann PJ, Anderson JE, Panzer AD, Pope EF, D'Cruz BN, Kim DD, Cohen JT. Comparing Cost-Per-QALYs Gained and Cost-Per-DALYs Averted Analyses. ISPOR 23rd International Meeting; Baltimore MD. May 2018. Poster presentation

Leech A, Kim D, Thorat T, Cohen JT, Neumann PJ. Cost-effectiveness thresholds in published cost-per-DALY studies. 12th World Congress of the International Health Economics Association  (IHEA); Boston, MA. July 2017. Long oral presentation, special organized session 

Anderson JE, Thorat T, Neumann PJ, Cohen JT. Implementation status of cost-effective vaccines in GAVI-eligible countries. ISPOR 22nd International Meeting; Boston, MA. May 2017. Poster presentation

Zhong Y, Thorat T, Cohen JT, Neumann PJ. A systematic review of studies reporting cost per disability-adjusted life year estimates. ISPOR 21st International Meeting; Washington DC. May 2016. Poster presentation